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Introduction
Aneuploidy is defined as an abnormal number of chromosomes 
and  is  one  of  the  most  prominent  features  in  solid  tumors. 
Karyotypes of tumors frequently range from 40 to 60 chromo-
somes (http://cgap.nci.nih.gov/Chromosomes/Mitelman), and it 
has been proposed that this level of aneuploidy is generated 
through an elevated rate of single chromosome missegregation 
as seen in chromosomal instability (CIN; Lengauer et al., 1998). 
However, the relationship between CIN and aneuploidy is un-
clear as we recently showed that aneuploid human cells do not 
propagate efficiently when chromosome missegregation rates 
are elevated to levels that are equivalent to tumor cells with CIN 
(Thompson and Compton, 2008). Moreover, mice heterozygous 
for mutations in genes encoding the checkpoint proteins Mad1 
and -2 and CENP-E have elevated chromosome missegregation 
rates  but  only  form  tumors  late  in  life  in  selective  tissues   
(Michel et al., 2001; Iwanaga et al., 2007; Weaver et al., 2007). 
Some groups argue that this delay in tumor formation is caused 
by a requirement for other cooperating mutations (Holland and 
Cleveland, 2009). Another possibility is that only specific chro-
mosome combinations promote tumorigenesis. Not all chromo-
somes may have the same impact on cell viability, but data from 
others showing reduced growth rates in aneuploid strains of 
budding  yeast  (Torres  et  al.,  2007)  and  mouse  cell  lines 
  (Williams et al., 2008) led those investigators to suggest that 
growth retardation in response to aneuploidy is a general phe-
nomenon (Torres et al., 2008). However, aneuploid cell lines 
isolated from tumors grow efficiently in culture, indicating that 
they have overcome this limitation. From these data, we hypoth-
esized that aneuploid tumor cells only arise from otherwise dip-
loid somatic cells when chromosome missegregation is coupled 
to the acquisition of tolerance for a nondiploid genome (Thompson 
and Compton, 2008). However, the mechanism underlying the 
intolerance for a nondiploid genome is unknown.
Results
To follow the fate of live cells that missegregate chromosomes, 
we generated HCT116 cells that expressed LacIGFP and had 
multiple copies of lacO integrated into a single chromosomal 
locus (Robinett et al., 1996; Straight et al., 1996). We chose to 
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step does not impair subsequent colony growth. Previously, 
we showed that HCT116 cells missegregate chromosomes at 
a rate of approximately one chromosome in every three cell   
divisions  using  this  monastrol  washout  strategy  (Thomp-
son and Compton, 2008). Because one third of the colonies 
formed after monastrol washout did not grow beyond two to 
three cells, it stands to reason that their growth is delayed in 
response  to  the  missegregation  of  a  chromosome  different 
from the one carrying the fluorescent mark.
Cell cycle delay or arrest under various conditions is often 
associated with activation of the tumor suppressor protein p53 
(Horn and Vousden, 2007). Using our chromosomally marked 
HCT116 cells, we induced chromosome missegregation with 
the monastrol washout strategy and then stained for p53 and 
one of its downstream targets, the cyclin-dependent kinase in-
hibitor p21 (Fig. 3). Staining intensities for both p53 and p21 
were low in HCT116 cells that segregated the marked chromo-
some normally but were elevated in cells that missegregated the 
marked chromosome. Of note, p53 and p21 staining intensities 
were elevated in both daughter cells: one that gained the chro-
mosome and its sibling that lost the chromosome (Fig. 3 A).   
In  cell  populations,  24  h  after  monastrol  washout,  elevated 
p53 and p21 staining was observed in 30% of HCT116 cells, 
which is consistent with the chromosome missegregation rate 
induced by this treatment (Fig. 3 B). Intensities for p53 and 
p21 were also elevated in 40% of immortalized RPE1 cells   
after monastrol washout, showing that similar effects occur 
in nontransformed cells (Fig. 3 B). When daughter cell pairs 
were directly examined, the specific subset of HCT116 cells 
that missegregated the marked chromosome showed that 87% 
of nuclei stained positive for p21 and >90% stained positive for 
p53, whereas only 40% of the cells that segregated the chro-
mosome properly were positive (Fig. 3 C). The percentage of 
p53- and p21-positive cells in general populations (30%) was 
skewed downward from the isolated pairs of daughter cells 
(40%) because of ongoing cell division of some cells (presum-
ably those with low levels of p21 and p53) during the 24 h 
period after monastrol washout in the population experiment. 
Similar results were observed using three different HCT116 
clones, each derived from independent lacO integrations with 
use HCT116 cells for this purpose because it is an established 
near-diploid colon cancer cell line that faithfully segregates 
chromosomes to maintain a stable karyotype (Lengauer et al., 
1997).  Cells  with  integrated  lacO  and  expressing  LacIGFP   
remained near diploid. The expressed LacIGFP bound to the 
chromosomal lacO site, producing a single, bright fluorescent 
mark in each interphase nucleus and unique marks on sister 
chromatids of mitotic chromosomes (Fig. 1). Accurate segre-
gation of this chromosome during mitosis yielded daughter 
cells with single marks in each nucleus, whereas missegrega-
tion yielded one daughter cell with no marks and the other with 
two (Fig. 2 A).
Using these chromosomally marked cells, we induced 
chromosome missegregation through a monastrol washout 
strategy (Cimini et al., 1999; Knowlton et al., 2006; Thomp-
son and Compton, 2008) and followed the fate of individual 
cell clones. We previously showed that this washout strategy 
elevates chromosome missegregation to levels where 33% 
of  cells  missegregate  at  least  one  chromosome  (Thompson 
and Compton, 2008). Mitotic cells were collected and plated 
at low density, and subsequent daughter cell pairs were iden-
tified  using  live  cell  fluorescent  microscopy  in  which  the 
marked chromosome either missegregated or segregated nor-
mally (Fig. 2 B). These cells were readily identifiable despite 
the low signal to noise ratio for the chromosomal spot when 
viewed under live imaging conditions (Fig. 2 B, arrowheads). 
As expected, untreated control cells that properly segregated 
the marked chromosome grew into large colonies over a 5-d 
period (Fig. 2, B and C). In contrast, cells that missegregated 
the marked chromosome failed to divide over the 5-d period 
(Fig. 2, B and C). In aggregate, colonies generated from cells 
that had undergone the drug washout strategy yet segregated 
the  marked  chromosome  correctly  showed  an  intermediate 
number  of  cells  compared  with  colonies  derived  from  un-
treated control cells and cells that missegregated the marked 
chromosome (Fig. 2 C) because they fall into two subsets.   
5 out of 15 cell colonies formed one subset that contained 
clones with three or fewer cells at the end of the 5 d of imaging. 
Colonies in the remaining subset had cell numbers similar to 
the untreated controls, indicating that the initial drug washout 
Figure 1.  HCT116 cells with a single marked chro-
mosome. Interphase (top left) and anaphase (bottom   
left)  cells  and  a  chromosome  spread  (right)  with 
LacIGFP  (green)  bound  to  multiple  copies  of  lacO 
integrated at a single chromosomal locus. DNA is 
stained with DAPI (blue). Bar, 10 µm.371 p53 suppresses aneuploidy • Thompson and Compton
Because the drug washout strategy involves an extended 
mitotic  arrest,  we  also  induced  chromosome  missegregation   
using an independent strategy whereby we transfected cells with 
siRNA specific to the centromere-associated kinesin-13 protein 
MCAK  (mitotic  centromere–associated  kinesin;  Wordeman 
and Mitchison, 1995). Depletion of MCAK increases levels of 
merotely (attachment of single kinetochores to microtubules   
a different chromosome labeled in each clone. This indicates 
that activation of the growth arrest/delay pathway involving the 
elevation of p21 and p53 levels is a general response to chro-
mosome missegregation and is not confined to the missegrega-
tion of a specific chromosome. The increase in p21 and p53 
after drug washout could also be detected by immunoblotting 
in both HCT116 and RPE1 cells (Fig. 3 D).
Figure 2.  Growth arrest after chromosome missegregation. (A) Schematic for proper segregation and missegregation of a single GFP-marked chromosome. 
(B) GFP (left) and phase-contrast images of daughter cells that either segregated the marked chromosome normally (top) or abnormally (bottom) at the indi-
cated times after drug washout. Arrowheads point to the LacIGFP/lacO chromosome mark. (C) Number of cells per clone after no treatment, monastrol wash-
out, and monastrol washout with missegregation (mis-seg) of the marked chromosome. Bars represent mean ± SEM (independent clones counted for control,   
n = 49; monastrol, n = 15; and monastrol/mis-seg, n = 22). Bars: (B, left) 10 µm; (B, right) 50 µm.JCB • VOLUME 188 • NUMBER 3 • 2010   372
Moreover,  live  cell  imaging  showed  that  MCAK  depletion 
did not significantly prolong the duration of mitosis (time 
from nuclear envelope breakdown [NEB] to anaphase onset) 
regardless of whether there were lagging chromosomes or not   
(Fig. 4, C and D). Staining intensities for both p53 and p21 were 
elevated in MCAK-deficient HCT116 cells that missegregated 
the marked chromosome (Fig. 4 E). Again, this was observed 
in both daughter cells. In the population of MCAK-deficient 
HCT116 cells that correctly segregated the marked chromosome, 
oriented toward both spindle poles) such that 30–40% of ana-
phase cells have lagging chromosomes, which promotes chro-
mosome missegregation (Maney et al., 1998; Kline-Smith et al., 
2004). 72 h after transfection of HCT116 cells with MCAK-
specific siRNA, MCAK protein levels were reduced to 35% of 
control levels (Fig. 4 A), and 33% of anaphase cells had lag-
ging chromosomes, compared with 10% in control untreated 
populations. MCAK depletion did not significantly increase the 
mitotic index of the cell population (P = 0.7376, 
2 test; Fig. 4 B).   
Figure 3.  p21 and p53 expression after chromosome missegregation. (A) HCT116 cells that have properly segregated (top) or missegregated (bottom) 
the marked chromosome 24 h after no treatment (top) or monastrol washout (bottom) were stained for p21, p53, and DAPI and with LacIGFP as indicated. 
(B) Percentage of nuclei staining positive for p21 and p53 24 h after control and monastrol washout in populations of HCT116 (left) and RPE1 (right) cells. 
Bars represent mean ± SEM of at least three experiments (>300 nuclei counted per condition per experiment). (C) Percentage of nuclei staining positive for 
p21 and p53 in chromosomally marked HCT116 cell line after control or monastrol washout in pairs of daughter cells that have either properly segregated 
or missegregated (mis-seg) the marked chromosome. Bars represent mean ± SEM of >180 cells in at least three experiments. (D) Immunoblots of untreated 
(ctrl) cells or cells after monastrol washout (mon) probed for p21, p53, and tubulin (loading control) in HCT116 and RPE1 cells. Bar, 10 µm.373 p53 suppresses aneuploidy • Thompson and Compton
p21  and  p53  staining  intensity  was  elevated  in  30%  and 
36%  of  nuclei,  respectively,  likely  caused  by  missegrega-
tion of another chromosome (Fig. 4 F). In the subset of cells 
that  missegregated  the  marked  chromosome,  80%  of  nuclei 
had elevated p21 staining intensity, and 76% had elevated p53   
(Fig. 4 F). As expected, most cells that properly segregated the 
marked  chromosome  after  transfection  with  MCAK-specific   
siRNA  grew  into  large  colonies  over  several  days  (Fig.  4,   
G and H). In contrast, cells that missegregated the marked chro-
mosome failed to divide over the same period (Fig. 4, G and H).   
As with the monastrol washout experiment, some cells that seg-
regated the marked chromosome properly displayed only three 
or fewer cells after 5 d (4 out of 16 colonies). This most likely 
reflects a subset of cells that underwent growth arrest induced 
by missegregation of an unmarked chromosome (Fig. 4 H).   
Many  of  the  remaining  colonies  that  were  transfected  with 
MCAK-specific siRNA grew into colonies with cell numbers 
comparable  with  control  cells.  However,  a  subset  of  these 
colonies (58%) contained only 5–10 cells after 5 d of growth. 
Growth of cells in this subset of colonies may have been limited 
by missegregation of a chromosome after the first division be-
cause of the lingering deficiency of MCAK induced by ongoing 
RNA interference (Fig. 4 H). These data show that chromosome 
missegregation in mitosis stabilizes p53 and the cyclin kinase 
inhibitor p21 in the subsequent G1 phase of the cell cycle and 
delays cell cycle progression. This is consistent with the obser-
vation that rat embryonic fibroblasts undergo a p53-dependent 
arrest in G1 after the formation of micronuclei because micro-
nuclei are often the consequence of chromosome missegrega-
tion caused by persistent merotelic attachment of microtubules 
to kinetochores (Sablina et al., 1998).
To confirm that proliferation defects after chromosome 
missegregation are not specific to transformed HCT116 cells, 
we induced chromosome missegregation in primary fetal lung 
fibroblast IMR-90 cells by depleting MCAK. 72 h after trans-
fection with MCAK-specific siRNA, IMR-90 cells displayed a 
sixfold increase in anaphases with lagging chromosomes, which 
is indicative of elevated rates of chromosome missegregation. 
Because  IMR-90  cells  are  highly  motile,  we  generated  cell 
clones after transfection with MCAK-specific siRNA by limit-
ing dilution into 96-well plates. We then counted the numbers of 
cells in each colony 5 d after plating. Under these conditions, 
the number of MCAK-deficient cells that failed to progress into 
colonies larger than one cell was significantly higher than that 
of control cells (Fig. S1). Although it is impossible to confirm 
chromosome missegregation in these primary fibroblasts, these 
results are consistent with the growth arrest we observed in 
HCT116 cells after chromosome missegregation.
DNA damage is a common mechanism to stabilize p53 
(Kastan et al., 1991). Under our experimental conditions, DNA 
damage may be induced at centromeric DNA in metaphase or 
early anaphase by spindle forces pulling merotelic kinetochores 
toward opposite poles. To test for DNA damage, we examined 
the levels of phosphorylated histone -H2AX, a modified his-
tone  which  rapidly  appears  at  sites  of  double-strand  breaks 
(Rogakou et al., 1998). Doxorubicin treatment induced DNA 
double-strand breaks and generated numerous -H2AX foci on 
mitotic chromosomes in anaphase cells (Fig. S2 A). However, 
-H2AX foci were not detected on lagging chromosomes that 
were induced using the monastrol washout strategy. We also 
examined interphase cells after doxorubicin treatment or 24 h 
after the monastrol washout (Fig. S2, B and C). As expected, 
nuclei in nearly all cells treated with doxorubicin stained posi-
tive for -H2AX. In contrast, nuclei from only a small frac-
tion of cells treated with monastrol washout stained positive for   
-H2AX, and this fraction is much smaller than the fraction of 
cells that would have missegregated a chromosome using this   
strategy  (Thompson  and  Compton,  2008)  and  is  not  differ-
ent from control cells. Thus, p53 stabilization in cells that mis-
segregate chromosomes is not the result of DNA damage caused 
by either the treatments used to induce missegregation or me-
chanical forces involved in missegregation.
If the stabilization of p53 contributes to the prolonged 
cell cycle delay after chromosome missegregation, loss of p53 
would permit the growth of aneuploid cells. To test this idea, we 
induced chromosome missegregation using a single monastrol 
washout in HCT116 cells lacking both alleles of the p53 gene 
(Bunz et al., 2002). We then determined the chromosome con-
tent of these cells as they propagated without further treatment 
using FISH with chromosome-specific probes (Fig. 5). The per-
centage of untreated p53-null cells that were aneuploid in the 
population was low and equivalent to wild-type HCT116 cells. 
Immediately after washout of monastrol, there was an equivalent 
increase in the percentage of aneuploid cells in both populations. 
The percentage of aneuploid cells in HCT116 wild-type popu-
lations returned to basal levels by 6 d after treatment (Fig. 5),   
as  previously  shown  (Thompson  and  Compton,  2008),  indi-
cating a failure of aneuploid cells to propagate efficiently. In 
contrast, the percentage of aneuploid cells in the population of 
HCT116 cells lacking p53 remained high 6 d after treatment, 
indicating that aneuploid cells in this population propagate and 
compete efficiently with diploid cells. This demonstrates that 
p53 is a key component of a pathway that provides intolerance 
to aneuploidy in somatic cultured human cells.
It has recently been shown that cell cycle arrest is medi-
ated by the p38 stress kinase in response to disruption of the 
cytoskeleton (Mikule et al., 2007; Uetake et al., 2007), so we 
tested whether the p38-dependent stress pathway participated in 
cell cycle delay in cells after chromosome missegregation. We 
induced chromosome missegregation in HCT116 cells as well 
as in immortalized but nontransformed RPE1 cells by using the 
monastrol  washout  strategy.  Using  FISH  with  chromosome- 
specific probes, we then determined the chromosome content 
of the populations as they propagated in the presence of either 
the p38 inhibitor SB203580 or the MAPK inhibitor PD98059   
(Fig. 6). As expected, the percentage of aneuploid cells in popu-
lations of both HCT116 and RPE1 cells increased immediately 
after monastrol washout. In the presence of the MAPK inhibi-
tor, the percentage of aneuploid cells in both populations de-
clined to background levels over time (Fig. 6 B). In contrast, 
the percentage of aneuploid cells in both populations remained 
elevated in the presence of the p38 inhibitor (Fig. 6 A). As p38 
is known to directly phosphorylate p53 in response to cellu-
lar stress (Bulavin et al., 1999), these data suggest that a stress   JCB • VOLUME 188 • NUMBER 3 • 2010   374375 p53 suppresses aneuploidy • Thompson and Compton
each individual colony (Table I). Because these percentages 
represent  aneusomy  for  specific  chromosomes,  it  is  likely 
that  the  overall  level  of  aneuploidy  in  these  colonies  was 
much higher. These data show that combining elevated chro-
mosome missegregation rates with increased tolerance for a 
nondiploid genome through p53 deficiency permits the con-
version of otherwise stable diploid cells into cells with the 
hallmarks of CIN.
We next tested the long-term genomic stability of cells 
derived from these p53-deficient colonies with CIN. We de-
rived subclones from each of the p53-deficient cell colonies 
shown in Table I by plating cells at low density. Subclones 
were grown for 27 more generations with no additional mon-
astrol washout, and we used FISH to determine the percentage 
of cells in each subclone that displayed chromosome numbers 
that deviated from the chromosomal mode (Table II). With one 
exception (p53
/ H subclone 4), all of the subclones displayed 
significant  deviation  from  the  modal  chromosome  number 
for at least two of the chromosomes analyzed. One subclone   
(p53
/ J subclone 2) showed exceptionally high deviations 
from the mode for all four chromosomes analyzed (Table II) 
and had a highly variable karyotype (Fig. S3). Karyotypes of 
these subclones often deviated from the normal modal chro-
mosome number of 45, indicating that they were aneuploid 
(HCT116 cells are disomic for all autosomes and have lost the 
Y chromosome; Fig. S3). Thus, these subclones are aneuploid 
in addition to being chromosomally unstable. It is not surprising 
response can induce a p53-dependent pathway to pause the cell 
cycle in response to chromosome missegregation.
Deficiency of p53 alone is not sufficient to generate aneu-
ploidy or CIN in HCT116 cells (Bunz et al., 2002). To test whether 
combining p53 deficiency with elevated chromosome missegre-
gation rates generates viable aneuploid and CIN cells, we in-
duced chromosome missegregation for several generations in 
p53-deficient HCT116 cells. We quantified modal chromosome 
number and the percentage of cells deviating from that mode in 
clonal populations of p53 wild-type and null cells after 27 con-
secutive generations. Both p53 wild-type and null HCT116 cells 
maintained a disomic modal copy number with very little devia-
tion from that mode for each chromosome analyzed in this 
clonal analysis (Table I). This confirms that these cells are near 
diploid and chromosomally stable and that p53 deficiency alone 
is insufficient to generate aneuploidy or CIN. Next, we used the 
monastrol washout strategy to increase chromosome missegre-
gation rates at each generation during the growth of colonies of 
both cell lines. Viable colonies of p53 wild-type cells failed to 
grow under these conditions, which is consistent with our pre-
vious findings showing that elevating chromosome missegrega-
tion rates alone is insufficient to generate viable aneuploid or 
CIN cells (Thompson and Compton, 2008). In contrast, elevat-
ing chromosome missegregation rates did not inhibit colony 
growth from p53-null HCT116 cells. All of these colonies dis-
played deviation from the modal chromosome number that 
was significantly elevated for each chromosome analyzed in 
Figure 4.  p21 and p53 expression and growth arrest after chromosome missegregation induced by MCAK depletion. (A) Western blot of HCT116 cells   
72 h after transfection with MCAK siRNA (+) or no siRNA () probing for MCAK and tubulin (loading control). (B) Mitotic indexes of HCT116 cells 72 h   
after MCAK or mock knockdown (kd). Bars represent mean ± SEM (three experiments; >500 cells in each experiment). (C) Still frames of control (top) or 
MCAK knockdown (bottom) in HCT116 cells expressing GFP-H2B, with time given in minutes after NEB. A lagging chromosome in MCAK knockdown 
anaphase is labeled with an arrowhead. (D) Timing (in minutes) from NEB to anaphase onset in HCT116 cells after control or MCAK knockdown. Bars 
represent mean ± SEM. (E) HCT116 cells that have properly segregated (top) or missegregated (bottom) the marked chromosome in control (top) or MCAK-
deficient cells (bottom) stained for p21, p53, and DAPI and with LacIGFP as indicated. (F) Percentage of nuclei positive for p21 and p53 after normal 
or missegregation (mis-seg) of the marked chromosome in control or MCAK-depleted HCT116 cells. Bars represent mean ± SEM of >150 cells in at least 
three experiments. (G) GFP (left) and phase-contrast images of daughter cells that segregated the marked chromosome normally (top) or abnormally in 
MCAK-deficient cells (bottom) at the indicated times after mitotic shake-off. Arrowheads point to the LacIGFP/lacO chromosome mark. (H) Number of cells 
in each clone after control or MCAK knockdown or MCAK knockdown cells that have missegregated the marked chromosome. Bars represent mean ± SEM 
(independent clones counted for control, n = 7; MCAK, n = 16; and MCAK/mis-seg, n = 14). Bars: (C) 5 µm; (E and G [left]) 10 µm; (G, right) 60 µm.
 
Figure 5.  p53-null HCT116 cells continue to proliferate after missegregation of chromosomes. p53 wild-type (left) and null (right) cells were treated 
with or without (control) monastrol, and mitotic cells were collected by shake-off, plated, and allowed to proliferate with no further treatment. At 4 h,   
2 d, and 6 d, cells were harvested, and FISH was performed using probes specific for chromosomes 3, 7, and 15. For each time point/condition, 
600 nuclei were counted per chromosome. Bars represent the mean percent deviation from the modal chromosome number, and error bars show SEM.   
*, P < 0.05; 
2 test.JCB • VOLUME 188 • NUMBER 3 • 2010   376
shifting the modal chromosome number of the population far 
from 45. Moreover, the inherent chromosome missegregation 
rate in these subclones is unlikely to reach the extremely high 
missegregation rate induced by monastrol washout (Thompson 
and  Compton,  2008),  explaining  why  these  subclones  have 
lower percentages of cells with chromosome numbers that de-
viate from the mode compared with the initial clones despite 
that most subclones had karyotypes with modes near 45 despite 
being CIN because there is no selective pressure for specific 
chromosome combinations under in vitro culture conditions, 
as would be expected for a tumor that is growing in situ. In 
the absence of selective pressure, CIN induces significant de-
viation from modal chromosome numbers and broadens the 
distribution of karyotypes in the population (Fig. S3) without 
Figure 6.  Inhibition of p38 stress kinase but not MAPK allows proliferation of aneuploid cells. (A and B) HCT116 cells with wild-type p53 and RPE1 cells 
were treated as described in Fig. 5. After shake-off, cells were grown in the presence of p38 inhibitor (SB203580; A) or MAPK inhibitor (PD98059; B) 
for the remainder of the experiment. For each time point/condition, 600 nuclei were counted per chromosome. Bars represent the mean percent deviation 
from the modal chromosome number, and error bars show SEM. *, P < 0.05; 
2 test.
Table I.  Modal chromosome number and percentage of cells that deviate from modal chromosome number in p53 wild-type and null clones
Cell line Mode (percent deviation)
Chr 2 Chr 4 Chr 7 Chr 15
p53
+/+ control (clone A) 2 (3.0)
a 2 (2.7)
a 2 (2.7) 2 (3.7)
a
p53
+/+ control (clone B) 2 (2.7) 2 (2.7) 2 (4.0)
a 2 (3.7)
p53
+/+ control (clone C) 2 (3.0) 2 (2.0) 2 (2.7) 2 (3.7)
p53
/ control (clone D) 2 (3.3) 2 (3.0) 2 (2.3) 2 (3.7)
p53
/ control (clone E) 2 (3.3) 2 (3.3) 2 (2.7) 2 (4.3)
p53
/ control (clone F) 2 (2.0) 2 (2.7) 2 (2.0) 2 (3.7)
p53
/ monastrol 27 d (clone G) 2 (18.0)
b 2 (26.0)
b 2 (10.0)
b 2 (21.0)
b
p53
/ monastrol 27 d (clone H) 2 (8.0)
b 2 (18.7)
b 2 (18.7)
b 2 (23.0)
b
p53
/ monastrol 27 d (clone I) 2 (17.3)
b 2 (24.3)
b 2 (20.0)
b 2 (29.7)
b
p53
/ monastrol 27 d (clone J) 2 (13.3)
b 2 (33.7)
b 2 (20.3)
b 2 (23.7)
b
Chr, chromosome. 300 nuclei were counted per chromosome per clone.
aClone used for statistical analysis.
bDeviation from mode is statistically significant (P < 0.05, 
2 test).377 p53 suppresses aneuploidy • Thompson and Compton
with  a  compromised  spindle  assembly  checkpoint  (Burds 
et  al.,  2005).  Our  data  show  that  the  p53  pathway  potently   
inhibits cell growth after missegregation of single chromosomes. 
The importance for this pathway to respond to imbalances in 
single chromosomes to prevent accumulation of aneuploid cells 
is readily apparent given that the human body contains millions 
of dividing cells at any given time (Alberts et al., 2002) and 
that a chromosome will spontaneously missegregate about once   
every 100 cell divisions (Cimini et al., 1999; Thompson and 
Compton, 2008).
The prolonged cell cycle delay that is imparted by the 
p53 pathway in response to chromosome missegregation rep-
resents one of several different cellular responses to aneu-
ploidy. For example, in some contexts, trisomy merely slows 
cellular growth rates (Williams et al., 2008), and budding yeast 
lack a p53 gene, so the responses reported in aneuploid yeast 
(Torres et al., 2007) cannot involve a p53-dependent pathway. 
In addition, there is a growing body of literature showing that 
aneuploidy is common in human and mouse neural progeni-
tor cells and neurons, and these probably retain a functional 
p53 pathway (Rehen et al., 2001, 2005; Kaushal et al., 2003; 
Yang et al., 2003; Kingsbury et al., 2005). For example, 33% 
of mouse neuroblasts are aneuploid compared with only 3.4% 
of adult lymphocytes (Rehen et al., 2001), and high levels of 
aneuploidy have also been seen in human brain cells (Rehen 
et al., 2005), indicating that those cell types tolerate an aneu-
ploid state. Moreover, it has been reported that deletion of p53 
in embryonic neural progenitor cells actually decreases the per-
centage of aneuploid cells, suggesting that p53-mediated arrest 
in response to aneuploidy is not the sole mechanism to inhibit 
aneuploid proliferation (McConnell et al., 2004). Also, levels of 
aneuploidy (often of sex chromosomes) in leukocytes increase 
as people age (Jacobs, et al., 1963), and there is no reported 
link to loss of p53 in these cases. Finally, aneuploidy increases 
in many tissues of mice that are heterozygous for mutations 
in genes encoding checkpoint proteins, and it is unlikely that   
these have all lost p53 function (Michel et al., 2001; Babu et al., 
2003; Baker et al., 2004; Iwanaga et al., 2007; Jeganathan 
et al., 2007; Weaver et al., 2007). Interestingly, Vanneste et al. 
(2009)  recently  showed  that  human  cleavage-stage  embryos 
show a high level of aneuploidy, with 19 out of 23 embryos   
similar generation times. These data show that the acquisition 
of tolerance for aneuploidy through p53 deficiency coupled 
with initial chromosome missegregation renders cells in these 
subclones genetically unstable and intrinsically CIN.
To discount the possibility that the p53
/ HCT116 cells 
have acquired an adaptation that permits their tolerance for non-
diploid genomes, we transfected our chromosomally marked 
HCT116 (p53
+/+) cells with p53-specific siRNA (Fig. S4). We 
induced chromosome missegregation by simultaneously trans-
fecting cells with MCAK-specific siRNA. Immunoblotting con-
firmed deficiency of p53 after siRNA transfection (Fig. S4 A), 
and an increase in lagging chromosomes at anaphase confirmed 
depletion of MCAK under these conditions (Fig. S4 B). As ex-
pected, cells that were deficient in p53 alone and that properly 
segregated the marked chromosome grew into large colonies 
over a 5-d period (Fig. S4 C). p53-deficient cells that missegre-
gated the marked chromosome because of MCAK deficiency 
also grew into large colonies over a 5-d period (Fig. S4 C). 
Thus, acute loss of p53 function from otherwise wild-type cells 
generates tolerance for the propagation of aneuploid cells and 
confirms our data generated using a cell line that has been engi-
neered to be deficient in p53.
Discussion
In  summary,  we  show  that  the  p53-dependent  pathway  is  a 
mechanism to limit the growth of diploid human cells in cul-
ture after chromosome missegregation. Our data fit a pathway 
whereby chromosome missegregation generates a p38 kinase–
dependent stress response that activates p53 to induce the cyclin 
kinase inhibitor p21, which delays cell cycle progression. The 
cellular stress that activates this pathway is most likely derived 
from the imbalance of products encoded by genes on the aneu-
somic chromosome. Trisomy has been shown to create gene 
dosage imbalances in both budding yeast and mammals (Torres 
et al., 2007; Williams et al., 2008), and, by logical extension, 
monosomy would also generate gene dosage imbalances. This 
provides a likely explanation for why our data show activation   
of the p53-dependent pathway in both the trisomic and the mono-
somic  daughter  cells  after  chromosome  missegregation. The   
p53 pathway has been shown to promote CIN when associated 
Table II.  Modal chromosome number and percentage of nonmodal cells in subclones generated from p53-null clones induced to persistently 
missegregate chromosomes for 27 generations
Cell line Mode (percent deviation)
Chr 2 Chr 4 Chr 7 Chr 15
p53
/ G subclone 1 2 (3.3)
a 2 (5.3) 2 (8.3)
a 2 (13.3)
a
p53
/ H subclone 1 2 (3.3) 2 (11.3)
a 2 (9.0)
a 2 (9.0)
a
p53
/ H subclone 2 2 (14.3)
a 2 (16.7)
a 2 (18.0)
a 2 (14.7)
a
p53
/ H subclone 3 2 (10.3)
a 2 (11.0)
a 2 (14.0)
a 2 (13.0)
a
p53
/ H subclone 4 2 (5.0) 2 (4.7) 2 (4.7) 2 (6.3)
p53
/ I subclone 1 2 (8.7)
a 2 (16.7)
a 2 (11.7)
a 2 (12.3)
a
p53
/ J subclone 1 2 (4.7) 2 (7.0) 2 (9.7)
a 2 (8.3)
a
p53
/ J subclone 2 4 (55.3)
a 2 (67.3)
a 4 (62.0)
a 2 (51.0)
a
Chr, chromosome. 300 nuclei were counted per chromosome per subclone.
aDeviation from mode is statistically significant compared with p53
+/+ controls in Table I (P < 0.05, 
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the p53 pathway (e.g., MCF7 breast carcinoma cells; Berns 
et al., 1995), or have inactivated regulators upstream of p53 
(e.g., p14
ARF expression is often lost by deletion or promoter   
hypermethylation in many tumors, and this loss occurs at 
early stages of tumorigenesis in some tumors; Esteller et al., 
2000; Vousden and Lu, 2002) or overexpress p53 inhibitors 
such as MDM2 or -4 (Toledo and Wahl, 2006).
The chromosome missegregation rate in human cancer 
cells with CIN is alarmingly high. CIN cells missegregate a 
chromosome every one to five divisions depending on the cell 
line (Thompson and Compton, 2008). These high missegre-
gation rates are matched by treatments that elevate merotely 
(Thompson and Compton, 2008) and are likely to be matched 
by securin depletion (Pfleghaar et al., 2005). The cell cycle 
delay imposed by repeated activation of the p53 pathway in re-
sponse to such frequent chromosome missegregation explains 
why otherwise diploid cells fail to survive when missegrega-
tion rates are elevated to levels equivalent to those of CIN 
cancer cells (Pfleghaar et al., 2005; Thompson and Compton, 
2008). This view may explain the reported increases in the 
percentage of aneuploid cells in populations of HCT116 cells 
that are heterozygous for mutations in the Mad2 gene (Michel 
et al., 2001). Chromosome missegregation rates were not di-
rectly measured in Mad2
+/ cells and may be lower than those 
of cells without securin or with elevated merotely because the 
percentage of aneuploid cells in populations of Mad2
+/ cells 
after 25 generations is similar to that observed in cells without 
securin or with elevated merotely after just 2 to 5 generations 
(Pfleghaar et al., 2005; Thompson and Compton, 2008). Thus, 
loss of p53 function can provide tolerance necessary for cel-
lular survival of otherwise diploid cells when chromosome 
missegregation rates reach those observed in human cancer 
cells with CIN.
Finally, our data fit a model whereby abnormal numbers 
of chromosomes disrupt the sensitive balance of mitotic pro-
teins, which in turn undermines faithful chromosome segrega-
tion  to  produce  further  aneuploidy  (Duesberg  et  al.,  1998, 
1999). If the dosage of any one of the many proteins involved 
in ensuring chromosome segregation fidelity is disrupted by the 
missegregation of the chromosome carrying that gene, the re-
sulting imbalance could further compromise chromosome seg-
regation  accuracy.  In  this  context,  we  demonstrate  that  by 
combining persistent chromosome missegregation with loss of 
the p53 pathway, we can convert stable diploid cells into aneu-
ploid cells that have karyotypes reminiscent of many human 
tumors. Moreover, we show that otherwise diploid cells be-
come intrinsically CIN once aneuploidy is induced in a genetic 
background  that  tolerates  chromosome  changes.  Although 
these results fit some aspects of the model proposed by Duesberg 
et al. (1998, 1999), there is divergence in other aspects because 
we show that aneuploidy and CIN only become self-propagat-
ing in a genetic background in which the p53 pathway has been 
inactivated. Thus, conversion of diploid progenitor cells into 
cells that are aneuploid and CIN takes two steps; reduction in 
chromosome segregation fidelity and acquisition of tolerance 
for a nondiploid genome that can arise through inactivation   
of the p53 pathway.
containing blastomeres with whole chromosome losses or 
gains. Embryonic stem cells have reduced levels of some check-
point proteins and a shortened G1 phase, suggesting that the 
developing embryo may relax checkpoint control and sacrifice 
chromosome  segregation  accuracy  to  expedite  proliferation 
(Egozi et al., 2007; Ambartsumyan and Clark, 2008). These 
embryologic adaptations to aneuploidy may underlie the viabil-
ity of trisomic mouse cells (Williams et al., 2008) and humans   
(i.e., Down’s syndrome). In addition, mosaic embryos contain-
ing both aneuploid and diploid cells can result in chromosomally 
normal fetuses (Vanneste et al., 2009). This selective retention 
of diploid cells may explain why mice heterozygous for muta-
tions in mitotic checkpoint genes are viable and have no obvi-
ous developmental defects (for review see Foijer et al., 2008). 
Collectively, these findings indicate that the cellular response 
to aneuploidy varies according to the specific cell context (i.e., 
tissue type, embryonic vs. somatic cell, etc.), and responses 
may vary depending on which chromosome has missegregated.   
Activation of the p53 pathway observed in this study appears to 
be critical to maintain the diploid karyotype of the population of 
cells grown under culture conditions. This may be the preferred 
response of somatic cells to prevent aneuploidy from contribut-
ing to the initiation or promotion of cancer that frequently arises 
in epithelial cell types. However, cells in other tissue contexts 
in humans and mice do not appear to respond to aneuploidy by 
activation of the p53 pathway.
p53 is one of the most highly mutated genes in cancer, 
and there is a strong correlation between aneuploid tumors 
and mutation of p53 (Campomenosi et al., 1998), supporting 
the idea that loss of p53 permits aneuploid cell propagation. 
For example, in some tumors and precancerous conditions 
including Barrett’s esophagus, p53 mutations arise in diploid 
cells before aneuploidy (Blount et al., 1994). Furthermore, 
diploid cells in culture often inactivate p53 and become aneu-
ploid at the same time during the immortalization process 
(Harvey et al., 1993), and cells from nonmalignant tissues in 
p53-null mice are often aneuploid (Fukasawa et al., 1997). 
However, it remains controversial whether mutation of p53 
is obligatory for aneuploid cell propagation. For example, 
aneuploid embryonic cells divide for multiple generations 
before embryonic lethality (Dobles et al., 2000; Kalitsis et al., 
2000; Williams et al., 2008) in contrast to the growth inhi-
bition we observe in cultured somatic cells. Moreover, p53 
is not lost or mutated in many aneuploid tumor cell lines 
(www.sanger.ac.uk/perl/genetics/CGP/cosmic), and in some 
cancers,  aneuploidy  appears  during  tumorigenesis  before 
p53 mutation (Baker et al., 1990). These tumors may harbor 
mutations in genes participating in other pathways that limit 
aneuploid cell growth or they may have impaired signaling 
upstream  or  downstream  of  p53.  For  example,  the  stress   
kinase  pathway  is  inactivated  in  some  tumors  (Greenman 
et al., 2007; Ventura et al., 2007) and attenuated in trans-
formed cells (Mikhailov et al., 2007), which would limit the 
capacity of aneuploidy-induced gene dosage imbalances to 
activate  the  p53  pathway. Alternatively,  some  tumor  cells 
are wild type for p53 but have mutations in the downstream 
cyclin kinase inhibitor genes, limiting the functionality of 379 p53 suppresses aneuploidy • Thompson and Compton
microscope with a Plan-Apochromat 60× NA 1.4 oil immersion objec-
tive.  0.25-µm  optical  sections  in  the  z  axis  were  collected.  Iterative 
restoration was performed using Phylum Live software. Autocontrast using 
Photoshop CS2 was applied to images. Nuclei were scored positive 
for p21 and p53 accumulation if pixel intensities inside the nucleus 
were at least 1.5 times and 2.0 times, respectively, higher than pixel 
intensities in untreated cells. Cells were scored positive for -H2AX foci 
when pixel intensities of foci matched or were brighter than single foci 
in doxorubicin-treated cells.
Live cell imaging of HCT116 GFP-H2B
Live imaging of HCT116 cells expressing GFP-H2B was performed as pre-
viously described (Thompson and Compton, 2008). HCT116 cells express-
ing H2BGFP growing on coverslips were transfected with MCAK siRNA as 
described in RNA interference. At 48–72 h, coverslips were mounted on 
modified rose chambers, and mitotic cells were imaged at 37°C with the 
60× objective on the aforementioned microscope by acquiring 27 0.5-µm 
optical sections in the z axis in the GFP channel at 1-min intervals. Images 
were deconvolved using Phylum Live, autocontrast was applied to images 
using Photoshop CS2, and still frames represent full volume projections. 
Time from NEB to anaphase was calculated by averaging movies from 
multiple MCAK knockdowns.
Immunoblotting
Total cell protein was separated by SDS-PAGE and transferred to a poly-
vinylidene fluoride membrane. Membranes were incubated with antibodies 
for p53 (1:2,500), p21 (1:500), MCAK (1:1,000), or tubulin (1:5,000; 
DM1-; Sigma-Aldrich) in 1% milk in Tris-buffered saline and detected with 
HRP-conjugated  secondary  antibodies  followed  by  chemiluminescence. 
Band intensities were quantified using ImageJ software (National Institutes 
of Health).
Monastrol washout time courses and CIN assay
Colony growth and FISH analyses were performed as previously described 
(Thompson and Compton, 2008). For clonal analyses, HCT116 p53
+/+ and 
p53
/ cells were grown in flasks. Once cells reached 70–80% conflu-
ency, they were treated with 100 µM monastrol or untreated for 8 h. Mitotics 
were isolated by shake-off, washed with PBS, and plated at very low density 
in 100-mm plates in fresh medium with no drug. Cells were allowed to 
  recover and finish dividing for 16 h and then treated with either monastrol 
or fresh media (control) for 8 h followed by two washes with PBS and once 
again incubated in fresh medium with no drug for 16 h. p53
+/+ and p53
/ 
control cells and p53
/ monastrol washout cells were treated in this manner 
for a total of 27 generations. At 15–20 generations, clones were har-
vested by trypsinization of colonies using cloning rings. At 27 generations, 
cells were harvested for FISH. For subclones derived from p53
/ monastrol 
27 d clones, at generation 27, a small percentage of the cells were plated 
at very low density, and subclones were grown for an additional 27 genera-
tions. Chromosome spreads were prepared from mitotic cells from popula-
tions of untreated p53
+/+ and p53
/ HCT116 cells and p53
/ subclones 
grown for >50 generations treated with 150 ng/ml nocodazole for 16 h. 
Cells were collected by trypsinization, briefly resuspended in 75 mM potas-
sium  chloride,  fixed,  washed  twice  in  3:1  methanol/acetic  acid  mix, 
dropped onto wet slides, air dried, and stained with DAPI.
For analysis of aneuploidy in the populations, HCT116 and RPE1 
cells were grown in flasks and treated with monastrol or fresh medium as 
described in the previous paragraph. Mitotic cells were isolated by shake-
off, washed with PBS, and replated in 100-mm dishes. Cells were grown 
in fresh medium with no further treatment, and at 4 h, 2 d, and 6 d 
(HCT116) or 8 d (RPE1), cells were harvested for FISH analysis. For kinase 
inhibitor experiments, medium containing 10 µM SB203580 or 50 µM 
PD98059 was added to the cells immediately after washout of monastrol, 
and cells were maintained in the presence of the drug for the remainder of 
the experiment.
Online supplemental material
Fig. S1 shows the percentage of IMR-90 cells that did not form a colony in 
MCAK knockdown and control cells. Fig. S2 displays -H2AX staining in 
RPE1 cells after monastrol washout or treatment with doxorubicin. Fig. S3 
displays histograms of karyotypes from untreated p53
+/+ and p53
/ cells 
and p53
/ subclones derived from clones treated for 27 d with monastrol 
washout and representative images of karyotypes. Fig. S4 shows the fate 
of cell clones that have missegregated chromosomes in cells depleted of 
both MCAK and p53. Online supplemental material is available at http://
www.jcb.org/cgi/content/full/jcb.200905057/DC1.
Materials and methods
Cell culture
Cells were maintained at 37°C with 5% CO2 in Dulbecco’s modified me-
dium (RPE1 and IMR-90) or McCoy’s 5a (HCT116) supplemented with 
10% FBS, 50 IU/ml penicillin, and 50 µg/ml streptomycin. Paired isogenic 
HCT116 cell lines with wild-type p53 or null p53 were a gift from B. Vogel-
stein (Johns Hopkins Oncology Center, Baltimore, MD). IMR-90 cells were 
purchased from the American Type Culture Collection and used between 
passage 3 and 7 (after we obtained them) for all experiments.
Plasmid transfections
HCT116 cells were transfected with p3-SS-GFP-lacI-NLS (LacIGFP plasmid; 
provided by W. Bickmore, Western General Hospital, Edinburgh, Scot-
land, UK; Chubb et al., 2002) using Lipofectamine 2000 (Invitrogen) and 
placed under hygromycin selection at 300 µg/ml for 20 d. Clones ex-
pressing LacIGFP were then transfected simultaneously with pJRC49 (plas-
mid with multiple lacO sites) and JCR41 (blasticidin resistance cassette; 
plasmids provided by W. Bickmore; Chubb et al., 2002) and placed under 
blasticidin selection at 2 µg/ml. Clones were isolated after 15–20 d and 
screened for LacIGFP expression and integration of lacO in a single locus, 
and selection was maintained by alternating blasticidin and hygromycin 
selection every 5–7 d. Three independent clones with the brightest chromo-
somal marks were examined for p21 and p53 expression in cells that 
missegregated  the  labeled  chromosome  after  monastrol  washouts  and 
MCAK  knockdown  (see  next  section).  Chromosome  spreads  were  per-
formed to verify that the labeled chromosome differed in each of the clones. 
One clone was chosen for live cell imaging (Fig. 2) because it had the 
highest signal to noise ratio.
RNA interference
MCAK was depleted using a published sequence (Cassimeris and Morabito, 
2004; Applied Biosystems). p53 was depleted using the predesigned se-
quence  5-GGGAGUUGUCAAGUCUUGC-3  from  Applied  Biosystems. 
200  nM  double-stranded  RNA  was  transfected  into  cells  using  Oligo-
fectamine as previously described (Ganem and Compton, 2004). Cells 
were analyzed or used for subsequent experiments 60–72 h later.
GFP and phase-contrast live cell imaging over extended time period
For monastrol washouts, cells were treated with 100 µM monastrol or re-
mained untreated (control) for 8 h. Mitotic cells were isolated by shake-off, 
washed with PBS, and plated at low density in 6-well plates. For MCAK 
knockdowns, cells were harvested 72 h after transfection as described in 
the previous section and plated at low density in 6-well plates. For both 
monastrol and MCAK experiments, 16 h after plating, pairs of daugh-
ter cells were screened for segregation of the marked chromosome by 
fluorescence microscopy, and a single focal plane GFP and phase image 
were acquired using a Plan Fluor 40× NA 0.6 ELW air objective on a 
microscope (TE 2000-E; Nikon) at 37°C equipped with a cooled charge-
coupled  device  camera  (Orca  ER;  Hamamatsu  Photonics).  The  spatial 
position of each pair of daughter cells was recorded using Phylum Live 
software (PerkinElmer), and phase-contrast images were acquired for each 
position at 24-h intervals for a total of 5 d. Cell clones were included in 
histograms only if they could be distinguished as two separate daughter 
cells to exclude cells that may have failed cytokinesis. Autocontrast was 
applied to images using Photoshop CS2 (Adobe).
IMR-90 cells were transfected with MCAK siRNA as described in the 
previous section. 72 h after transfection, cells were split into 96-well plates 
at a concentration of one cell per every two wells. Cells were incubated for 
an additional 5 d, and the number of cells per well was counted.
Fixed cell imaging
Cells were fixed in 3.5% PFA and stained, and images were acquired 
as previously described (Thompson and Compton, 2008). For monastrol 
washouts, cells were grown in flasks, treated with 100 µM monastrol for   
8 h, isolated by mitotic shake-off, washed with PBS, plated on coverslips, 
and incubated for 24 h. For MCAK knockdowns, cells were grown and 
transfected on coverslips and fixed at 72 h after siRNA transfection. 1 µM 
doxorubicin was added to cells 4 h before fixation (interphase) or at 0.5 µM   
50 min before fixation for mitotic cells. Antibodies were specific for p21 
(1:500; Santa Cruz Biotechnology, Inc.), p53 (1:1,000; Santa Cruz 
Biotechnology, Inc.), anticentromere antibody (1:1,000; provided by 
K. Sullivan, National University of Ireland, Galway, Ireland), and/or 
-H2AX  (1:1,000;  Novus  Biologicals)  and  were  detected  with  FITC, 
Texas red, and/or Cy5. Images were acquired on the aforementioned JCB • VOLUME 188 • NUMBER 3 • 2010   380
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